Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL28201995 | 0.91 | CA2 (0.42) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL2927237 | 0.91 | — | — | |
| Phosphoric Acid SCHEMBL28503265 | 0.91 | — | — | |
| Phosphoric Acid SCHEMBL28325358 | 0.91 | — | — | |
| Phosphoric Acid SCHEMBL4580760 | 0.91 | CA2 (0.42) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL28970696 | 0.91 | — | — | |
| Phosphoric Acid SCHEMBL28398462 | 0.91 | — | — | |
| Phosphoric Acid SCHEMBL28899247 | 0.91 | CA2 (0.42) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL4050805 | 0.91 | — | — | |
| Phosphoric Acid SCHEMBL27738710 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113403619-A | near-infrared/pH dual-response iodine-loaded titanium alloy implant and preparation method thereof | 浙江大学 | 2021-09-17 | — | — | CN | claimed |
| EP-3586882-B1 | ANTIBACTERIAL BIOLOGICAL IMPLANT | PROSTEC CO LTD (JP) | 2023-02-22 | — | — | EP | disclosed |
| EP-3981444-A1 | METHODS OF MODIFYING THE POROUS SURFACE OF IMPLANTS | Biomet Manufacturing, LLC (US) | 2022-04-13 | — | — | EP | disclosed |
| EP-3586883-B1 | METHOD FOR PRODUCING ANTIBACTERIAL BIOLOGICAL IMPLANT | PROSTEC CO LTD (JP) | 2021-11-17 | — | — | EP | disclosed |
| US-20210186703-A1 | METHODS OF MODIFYING THE POROUS SURFACE OF IMPLANTS | BIOMET MFG LLC (US) | 2021-06-24 | — | — | US | disclosed |
| US-10980914-B2 | Antibacterial biological implant | PROSTEC CO., LTD. (JP) | 2021-04-20 | — | — | US | disclosed |
| EP-3391915-B1 | METHODS OF MODIFYING THE POROUS SURFACE OF IMPLANTS | BIOMET MFG LLC (US) | 2021-04-14 | — | — | EP | disclosed |
| US-10940234-B2 | Method for producing antibacterial biological implant | PROSTEC CO., LTD. (JP) | 2021-03-09 | — | — | US | disclosed |
| US-10893944-B2 | Methods of modifying the porous surface of implants | BIOMET MANUFACTURING, LLC (US) | 2021-01-19 | — | — | US | disclosed |
| US-10668187-B2 | Medical supplies and method of producing the same | PROSTEC CO., LTD. (JP) | 2020-06-02 | — | — | US | disclosed |
| EP-3391915-A2 | METHODS OF MODIFYING THE POROUS SURFACE OF IMPLANTS | Biomet Manufacturing, LLC (US) | 2018-10-24 | — | — | EP | disclosed |
| US-20180280143-A1 | METHODS OF MODIFYING THE POROUS SURFACE OF IMPLANTS | BIOMET MANUFACTURING, LLC | 2018-10-04 | — | — | US | disclosed |
| US-20180243483-A1 | MEDICAL SUPPLIES AND METHOD OF PRODUCING THE SAME | PROSTEC CO LTD (JP) | 2018-08-30 | — | — | US | disclosed |
| US-9889231-B2 | Medical supplies and method of producing the same | PROSTEC CO., LTD. (JP) | 2018-02-13 | — | — | US | disclosed |
| CN-102281906-B | Medical part and manufacturing method therefor | PROSTEC CO LTD | 2014-08-27 | — | — | CN | disclosed |
| US-20130240365-A1 | MEDICAL SUPPLIES AND METHOD OF PRODUCING THE SAME | PROSTEC CO., LTD. (JP) | 2013-09-19 | — | — | US | disclosed |
| EP-2371398-B1 | MEDICAL SUPPLIES AND METHOD OF PRODUCING THE SAME | PROSTEC CO LTD (JP) | 2013-05-15 | — | — | EP | disclosed |
| US-20110313539-A1 | MEDICAL SUPPLIES AND METHOD OF PRODUCING THE SAME | PROSTEC CO., LTD. (JP) | 2011-12-22 | — | — | US | disclosed |
| CN-102281906-A | Medical part and manufacturing method therefor | — | 2011-12-14 | — | — | CN | disclosed |
| EP-2371398-A1 | MEDICAL PART AND MANUFACTURING METHOD THEREFOR | Prostec Co., Ltd. (JP) | 2011-10-05 | — | — | EP | disclosed |